Comparison of the protonation of isophosphoramide mustard and phosphoramide mustard. 1995

K K Millis, and M E Colvin, and E M Shulman-Roskes, and S M Ludeman, and O M Colvin, and M P Gamcsik
Department of Radiology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA.

The alkylating agent isophosphoramide mustard (IPM) spontaneously forms a relatively stable aziridine derivative which can be directly observed using NMR spectroscopy. The protonations of IMP and its aziridine were probed using 1H, 31P, 15N, and 17O NMR spectroscopy. The positions of the 31P, 15N, and 17O resonances of IPM between pH 2 and 10 each exhibit a single monobasic titration curve with the same pKa of 4.31 +/- 0.02. On the basis of a comparison with other compounds and our earlier work with phosphoramide mustard, the NMR results for IPM indicate that protonation occurs at nitrogen and not oxygen. Over this same pH range, each of the 1H, 31P, and 15N resonances of IPM-aziridine also show a single monobasic titration with a pKa of 5.30 +/- 0.09. The magnitude of the change in chemical shifts suggests that the protonation of the IPM-aziridine occurs at the ring nitrogen. Theoretical gas-phase calculations of PM, IPM, and IPM-aziridine suggest O-protonation to be more likely; however, aqueous phase calculations predict the N-protonated forms to be most stable. Furthermore, for PM and IPM-aziridine, which contain nonequivalent nitrogens, the theoretical calculations and experimental data both agree as to which nitrogen undergoes protonation. These results suggest that the IMP-aziridine remains unprotonated under physiological conditions and may, in part, explain the lower alkylating activity of IPM as compared to PM.

UI MeSH Term Description Entries
D007069 Ifosfamide Positional isomer of CYCLOPHOSPHAMIDE which is active as an alkylating agent and an immunosuppressive agent. Isofosfamide,Isophosphamide,Asta Z 4942,Holoxan,Iphosphamide,Iso-Endoxan,NSC-109,724,NSC-109724,Iso Endoxan,NSC 109,724,NSC 109724,NSC109,724,NSC109724
D008956 Models, Chemical Theoretical representations that simulate the behavior or activity of chemical processes or phenomena; includes the use of mathematical equations, computers, and other electronic equipment. Chemical Models,Chemical Model,Model, Chemical
D009682 Magnetic Resonance Spectroscopy Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING). In Vivo NMR Spectroscopy,MR Spectroscopy,Magnetic Resonance,NMR Spectroscopy,NMR Spectroscopy, In Vivo,Nuclear Magnetic Resonance,Spectroscopy, Magnetic Resonance,Spectroscopy, NMR,Spectroscopy, Nuclear Magnetic Resonance,Magnetic Resonance Spectroscopies,Magnetic Resonance, Nuclear,NMR Spectroscopies,Resonance Spectroscopy, Magnetic,Resonance, Magnetic,Resonance, Nuclear Magnetic,Spectroscopies, NMR,Spectroscopy, MR
D010752 Phosphoramide Mustards A group of nitrogen mustard compounds which are substituted with a phosphoramide group or its derivatives. They are usually cytotoxic and used as antineoplastic agents. Mustards, Phosphoramide
D011522 Protons Stable elementary particles having the smallest known positive charge, found in the nuclei of all elements. The proton mass is less than that of a neutron. A proton is the nucleus of the light hydrogen atom, i.e., the hydrogen ion. Hydrogen Ions,Hydrogen Ion,Ion, Hydrogen,Ions, Hydrogen,Proton
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D013816 Thermodynamics A rigorously mathematical analysis of energy relationships (heat, work, temperature, and equilibrium). It describes systems whose states are determined by thermal parameters, such as temperature, in addition to mechanical and electromagnetic parameters. (From Hawley's Condensed Chemical Dictionary, 12th ed) Thermodynamic

Related Publications

K K Millis, and M E Colvin, and E M Shulman-Roskes, and S M Ludeman, and O M Colvin, and M P Gamcsik
November 1993, Journal of medicinal chemistry,
K K Millis, and M E Colvin, and E M Shulman-Roskes, and S M Ludeman, and O M Colvin, and M P Gamcsik
August 1989, Journal of medicinal chemistry,
K K Millis, and M E Colvin, and E M Shulman-Roskes, and S M Ludeman, and O M Colvin, and M P Gamcsik
January 2003, Acta poloniae pharmaceutica,
K K Millis, and M E Colvin, and E M Shulman-Roskes, and S M Ludeman, and O M Colvin, and M P Gamcsik
January 1994, Cancer chemotherapy and pharmacology,
K K Millis, and M E Colvin, and E M Shulman-Roskes, and S M Ludeman, and O M Colvin, and M P Gamcsik
October 1998, The Journal of organic chemistry,
K K Millis, and M E Colvin, and E M Shulman-Roskes, and S M Ludeman, and O M Colvin, and M P Gamcsik
September 2004, Chemical research in toxicology,
K K Millis, and M E Colvin, and E M Shulman-Roskes, and S M Ludeman, and O M Colvin, and M P Gamcsik
March 1976, Cancer research,
K K Millis, and M E Colvin, and E M Shulman-Roskes, and S M Ludeman, and O M Colvin, and M P Gamcsik
January 2017, Reproductive toxicology (Elmsford, N.Y.),
K K Millis, and M E Colvin, and E M Shulman-Roskes, and S M Ludeman, and O M Colvin, and M P Gamcsik
January 2013, Acta poloniae pharmaceutica,
K K Millis, and M E Colvin, and E M Shulman-Roskes, and S M Ludeman, and O M Colvin, and M P Gamcsik
November 1980, Cancer research,
Copied contents to your clipboard!